PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SBIO vs. ARKG
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between SBIO and ARKG is 0.80, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


-0.50.00.51.00.8

Performance

SBIO vs. ARKG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ALPS Medical Breakthroughs ETF (SBIO) and ARK Genomic Revolution Multi-Sector ETF (ARKG). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%JulyAugustSeptemberOctoberNovemberDecember
3.73%
-3.74%
SBIO
ARKG

Key characteristics

Sharpe Ratio

SBIO:

0.52

ARKG:

-0.59

Sortino Ratio

SBIO:

0.91

ARKG:

-0.66

Omega Ratio

SBIO:

1.10

ARKG:

0.93

Calmar Ratio

SBIO:

0.30

ARKG:

-0.30

Martin Ratio

SBIO:

1.68

ARKG:

-1.00

Ulcer Index

SBIO:

9.05%

ARKG:

23.85%

Daily Std Dev

SBIO:

29.33%

ARKG:

40.25%

Max Drawdown

SBIO:

-63.06%

ARKG:

-80.10%

Current Drawdown

SBIO:

-44.84%

ARKG:

-78.81%

Returns By Period

In the year-to-date period, SBIO achieves a 6.29% return, which is significantly higher than ARKG's -27.83% return.


SBIO

YTD

6.29%

1M

-5.78%

6M

5.08%

1Y

13.27%

5Y*

-3.88%

10Y*

N/A

ARKG

YTD

-27.83%

1M

1.37%

6M

-2.83%

1Y

-26.09%

5Y*

-7.08%

10Y*

1.96%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


SBIO vs. ARKG - Expense Ratio Comparison

SBIO has a 0.50% expense ratio, which is lower than ARKG's 0.75% expense ratio.


ARKG
ARK Genomic Revolution Multi-Sector ETF
Expense ratio chart for ARKG: current value at 0.75% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.75%
Expense ratio chart for SBIO: current value at 0.50% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.50%

Risk-Adjusted Performance

SBIO vs. ARKG - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ALPS Medical Breakthroughs ETF (SBIO) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SBIO, currently valued at 0.52, compared to the broader market0.002.004.000.52-0.59
The chart of Sortino ratio for SBIO, currently valued at 0.91, compared to the broader market-2.000.002.004.006.008.0010.000.91-0.66
The chart of Omega ratio for SBIO, currently valued at 1.10, compared to the broader market0.501.001.502.002.503.001.100.93
The chart of Calmar ratio for SBIO, currently valued at 0.30, compared to the broader market0.005.0010.0015.000.30-0.30
The chart of Martin ratio for SBIO, currently valued at 1.68, compared to the broader market0.0020.0040.0060.0080.00100.001.68-1.00
SBIO
ARKG

The current SBIO Sharpe Ratio is 0.52, which is higher than the ARKG Sharpe Ratio of -0.59. The chart below compares the historical Sharpe Ratios of SBIO and ARKG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
0.52
-0.59
SBIO
ARKG

Dividends

SBIO vs. ARKG - Dividend Comparison

SBIO's dividend yield for the trailing twelve months is around 3.47%, while ARKG has not paid dividends to shareholders.


TTM2023202220212020201920182017
SBIO
ALPS Medical Breakthroughs ETF
3.47%0.22%0.00%0.00%0.00%0.04%2.79%1.77%
ARKG
ARK Genomic Revolution Multi-Sector ETF
0.00%0.00%0.00%0.62%0.85%3.14%1.94%1.34%

Drawdowns

SBIO vs. ARKG - Drawdown Comparison

The maximum SBIO drawdown since its inception was -63.06%, smaller than the maximum ARKG drawdown of -80.10%. Use the drawdown chart below to compare losses from any high point for SBIO and ARKG. For additional features, visit the drawdowns tool.


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%JulyAugustSeptemberOctoberNovemberDecember
-44.84%
-78.81%
SBIO
ARKG

Volatility

SBIO vs. ARKG - Volatility Comparison

The current volatility for ALPS Medical Breakthroughs ETF (SBIO) is 9.71%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 14.47%. This indicates that SBIO experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


6.00%8.00%10.00%12.00%14.00%16.00%JulyAugustSeptemberOctoberNovemberDecember
9.71%
14.47%
SBIO
ARKG
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab